MPR Weekly Dose 126 — Change to Monkeypox Vaccine Supply; Myfembree Indication Expanded; Amazon Among Companies to Receive FDA Warning; Impurity in Diabetes Tx episode artwork

EPISODE · Aug 11, 2022 · 10 MIN

MPR Weekly Dose 126 — Change to Monkeypox Vaccine Supply; Myfembree Indication Expanded; Amazon Among Companies to Receive FDA Warning; Impurity in Diabetes Tx

from MPR Weekly Dose

New authorization for intradermal administration of monkeypox vaccine; a new approval for endometriosis pain; Amazon is among the companies to receive an FDA Warning Letter for selling unapproved drugs; a diabetes drug is found to contain a possible carcinogen; and a new scale that measures peripheral impedance and pulse rate.  

Episode metadata supplied by the publisher feed · Published Aug 11, 2022

Embed this episode

Ready to play

MPR Weekly Dose 126 — Change to Monkeypox Vaccine Supply; Myfembree Indication Expanded; Amazon Among Companies to Receive FDA Warning; Impurity in Diabetes Tx

0:00 10:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MPR Weekly Dose?

This episode is 10 minutes long.

When was this MPR Weekly Dose episode published?

This episode was published on August 11, 2022.

Can I download this MPR Weekly Dose episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!